• linkedin
  • Increase Font
  • Sharebar

    FDA temporarily shutters ‘filthy’ compounding pharmacy


    FDA recently announced it had closed the operations of a major Florida compounder due to drugs that contained “filthy, putrid, or decomposed substances.” Several years ago, drugs compounded by Franck’s Compounding Lab caused eye infections that led to vision loss.

    FDA, via the U.S. Department of Justice, has prohibited Paul W. Franck of Ocala, Florida, from manufacturing and distributing compounded drugs until he complies with the FD&C Act and its regulations.

    Courtesy: Shutterstock/Muellek JosefFranck owned and operated numerous compounding pharmacies over the past 20 years, including Franck’s Lab Inc., doing business as Franck’s Compounding Lab, and Franck’s Lab Inc., doing business as Trinity Care Solutions.

    FDA said Franck manufactured drugs that were considered adulterated under the FD&C Act because they contained filthy, putrid, or decomposed substances; were prepared, packed, or held under insanitary conditions; and fell below the quality and/or purity standards they purported to possess.

    “Mr. Franck risked the health of the American public by compounding drugs under unacceptable conditions,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research. “Today’s action reflects the FDA’s continued efforts to take appropriate and aggressive enforcement action against those who put patients’ health at risk by choosing not to follow the law.”

    In 2014, Trinity Care Solutions recalled all sterile drugs and ceased compounding operations after a FDA inspection revealed violations that could compromise drug sterility.

    Christine Blank
    Contributing Editor Christine Blank is a freelance writer based in Florida.

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • Anonymous
      Is it just me or is there something decidedly wrong with the practice of pharmacy in the State of Florida? Over the years there seems to be a disproportionate amount of reporting about drug diversion, shoddy compounding (although that may be from just one source), and other deficiencies which, if there were a functional Board of Pharmacy, shouldn't ever exist. Is the FL BofP completely useless? Why do the Feds (DEA, FDA) always have to step in to address issues which a competent BofP should be on top of? Something is truly rotten in the State of Florida.